+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

RNA Analysis/Transcriptomics Market Research Report by Product (Instruments, Reagents/Consumables, and Services), Technology, Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5206433
  • Report
  • April 2022
  • Region: Global
  • 195 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Acobiom
  • BaseClear B.V.
  • CD Genomics
  • Fluidigm Corporation
  • Illumina, Inc.
  • Lexogen GmbH
The Global RNA Analysis/Transcriptomics Market size was estimated at USD 4,415.92 million in 2021, USD 4,866.93 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.39% to reach USD 7,991.15 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the RNA Analysis/Transcriptomics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Instruments, Reagents/Consumables, Services, and Software.
  • Based on Technology, the market was studied across Microarrays, Polymerase Chain Reaction, RNA Interference, and Sequencing.
  • Based on Application, the market was studied across Clinical Diagnostics, Comparative Transcriptomics, Drug Discovery, and Toxicogenomics.
  • Based on End User, the market was studied across Academic & Research Institutes, Contract Research Organizations, Hospitals, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for RNA Analysis/Transcriptomics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the RNA Analysis/Transcriptomics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global RNA Analysis/Transcriptomics Market, including Acobiom, Agilent Technologies, Inc., ALLSEQ, INC., BaseClear B.V., Bio-Rad Laboratories, Inc., bioMérieux SA, CD Genomics, Cyagen Biosciences Inc., Fluidigm Corporation, GenXPro GmbH, Illumina, Inc., LC Sciences LLC, Lexogen GmbH, Merck KGaA, Nucleome Informatics Private Limited, Promega Corporation, Psomagen, Inc., Sequentia Biotech SL, Takara Bio USA, Inc., and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global RNA Analysis/Transcriptomics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global RNA Analysis/Transcriptomics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global RNA Analysis/Transcriptomics Market?
4. What is the competitive strategic window for opportunities in the Global RNA Analysis/Transcriptomics Market?
5. What are the technology trends and regulatory frameworks in the Global RNA Analysis/Transcriptomics Market?
6. What is the market share of the leading vendors in the Global RNA Analysis/Transcriptomics Market?
7. What modes and strategic moves are considered suitable for entering the Global RNA Analysis/Transcriptomics Market?
Frequently Asked Questions about the Global RNA Analysis/Transcriptomics Market

What is the estimated value of the Global RNA Analysis/Transcriptomics Market?

The Global RNA Analysis/Transcriptomics Market was estimated to be valued at $4415.9 Million in 2021.

What is the growth rate of the Global RNA Analysis/Transcriptomics Market?

The growth rate of the Global RNA Analysis/Transcriptomics Market is 10.3%, with an estimated value of $7991.2 Million by 2027.

What is the forecasted size of the Global RNA Analysis/Transcriptomics Market?

The Global RNA Analysis/Transcriptomics Market is estimated to be worth $7991.2 Million by 2027.

Who are the key companies in the Global RNA Analysis/Transcriptomics Market?

Key companies in the Global RNA Analysis/Transcriptomics Market include Acobiom, Agilent Technologies, Inc., ALLSEQ, INC., BaseClear B.V., Bio, Rad Laboratories, Inc., bioMérieux SA, CD Genomics and Fluidigm Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Acobiom
  • BaseClear B.V.
  • CD Genomics
  • Fluidigm Corporation
  • Illumina, Inc.
  • Lexogen GmbH

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for personalized medicine
5.1.1.2. Growing applications of RNA sequencing in transcriptomics along with need for multiplexed RNA quantification
5.1.1.3. Growing pharmaceutical and biotechnology R&D expenditure and government funding for omics
5.1.2. Restraints
5.1.2.1. High capital investments
5.1.2.2. Issues related to data management
5.1.3. Opportunities
5.1.3.1. Increasing focus on biomarker discovery
5.1.3.2. High growth opportunities in emerging economies
5.1.3.3. Rising focus on outsourcing
5.1.4. Challenges
5.1.4.1. Lack of effective bioinformatics tools
5.1.4.2. Dearth of skilled professionals
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. RNA Analysis/Transcriptomics Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents/Consumables
6.4. Services
6.5. Software
7. RNA Analysis/Transcriptomics Market, by Technology
7.1. Introduction
7.2. Microarrays
7.3. Polymerase Chain Reaction
7.4. RNA Interference
7.5. Sequencing
8. RNA Analysis/Transcriptomics Market, by Application
8.1. Introduction
8.2. Clinical Diagnostics
8.3. Comparative Transcriptomics
8.4. Drug Discovery
8.5. Toxicogenomics
9. RNA Analysis/Transcriptomics Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Hospitals
9.5. Pharmaceutical & Biotechnology Companies
10. Americas RNA Analysis/Transcriptomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific RNA Analysis/Transcriptomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa RNA Analysis/Transcriptomics Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Acobiom
14.2. Agilent Technologies, Inc.
14.3. ALLSEQ, INC.
14.4. BaseClear B.V.
14.5. Bio-Rad Laboratories, Inc.
14.6. bioMérieux SA
14.7. CD Genomics
14.8. Cyagen Biosciences Inc.
14.9. Fluidigm Corporation
14.10. GenXPro GmbH
14.11. Illumina, Inc.
14.12. LC Sciences LLC
14.13. Lexogen GmbH
14.14. Merck KGaA
14.15. Nucleome Informatics Private Limited
14.16. Promega Corporation
14.17. Psomagen, Inc.
14.18. Sequentia Biotech SL
14.19. Takara Bio USA, Inc.
14.20. Thermo Fisher Scientific, Inc.
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: DYNAMICS
FIGURE 2. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 3. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2027
FIGURE 5. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS/CONSUMABLES, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS/CONSUMABLES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SERVICES, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 14. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 16. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY MICROARRAYS, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA INTERFERENCE, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 25. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2027
FIGURE 27. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TOXICOGENOMICS, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TOXICOGENOMICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 36. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2027
FIGURE 38. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2027 (USD MILLION)
FIGURE 41. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 43. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 44. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (USD MILLION)
FIGURE 45. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 46. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: FPNV POSITIONING MATRIX
FIGURE 77. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS/CONSUMABLES, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS/CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS/CONSUMABLES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS/CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS/CONSUMABLES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY MICROARRAYS, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA INTERFERENCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA INTERFERENCE, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA INTERFERENCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA INTERFERENCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TOXICOGENOMICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TOXICOGENOMICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TOXICOGENOMICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TOXICOGENOMICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TOXICOGENOMICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 68. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 73. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 78. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 79. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 80. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 83. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 84. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 85. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 112. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 116. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: SCORES
TABLE 118. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: BUSINESS STRATEGY
TABLE 119. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: PRODUCT SATISFACTION
TABLE 120. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: RANKING
TABLE 121. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 122. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: MERGER & ACQUISITION
TABLE 123. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 124. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 125. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: INVESTMENT & FUNDING
TABLE 126. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 127. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Acobiom
  • Agilent Technologies, Inc.
  • ALLSEQ, INC.
  • BaseClear B.V.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • CD Genomics
  • Cyagen Biosciences Inc.
  • Fluidigm Corporation
  • GenXPro GmbH
  • Illumina, Inc.
  • LC Sciences LLC
  • Lexogen GmbH
  • Merck KGaA
  • Nucleome Informatics Private Limited
  • Promega Corporation
  • Psomagen, Inc.
  • Sequentia Biotech SL
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...